Improved skin allograft tolerance induced by treatment with donor splenocytes and an extended course of anti-CD154 monoclonal antibody.
Markees
T
T
University of Massachusetts Medical School, Worcester, MA 01605, USA.
Phillips
N
N
Gordon
E
E
Noelle
R J
RJ
Mordes
J P
JP
Greiner
D L
DL
Rossini
A A
AA
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D023201:CD40 Ligand; D004334:Drug Administration Schedule; D005260:Female; D007165:Immunosuppression Therapy / Q000379:methods*; D017710:Lymphocyte Transfusion; D008297:Male; D008562:Membrane Glycoproteins / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D016038:Skin Transplantation / Q000276:immunology*; D013154:Spleen / Q000276:immunology*; D013997:Time Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D008562:Membrane Glycoproteins; D023201:CD40 Ligand